Noguchi labs: “We received the leftovers” – Mahama recalls Africa’s struggle for COVID-19 vaccines

Noguchi labs: “We received the leftovers” – Mahama recalls Africa’s struggle for COVID-19 vaccines

President John Dramani Mahama says the newly commissioned vaccine research laboratories at the Noguchi Memorial Institute for Medical Research will strengthen Ghana’s capacity to develop vaccines locally and reduce its dependence on foreign supplies.

Speaking at the commissioning ceremony on Wednesday, November 18, 2026, he said the COVID-19 pandemic exposed weaknesses in global vaccine supply chains, leaving many African countries struggling to access vaccines.

“The Western countries satisfied their domestic demand before they passed on the leftovers to us. We are just lucky that God is an African and he gave us the immunity not to die, even though we didn’t have the vaccines, we were able to survive the COVID pandemic,” he said.

President Mahama said the newly established mRNA and protein laboratories would provide scientists with the facilities to conduct research and develop vaccines locally.

“The mRNA and protein laboratories will provide scientists with a place to conduct research, test new ideas, and collaborate,” he said.

He added that the facilities would help Ghana strengthen its preparedness for future outbreaks and pursue vaccine self-sufficiency.

“They will also lay a firm foundation for vaccine development in Ghana and across the continent, Our scientists will be able to contribute to research addressing global health challenges, strengthen our preparedness for future outbreaks, and advance our long-term goals of vaccine self-sufficiency and health sovereignty,” he said.

The President also disclosed that two Ghanaian biomedical companies, Atlantic Life Sciences and DEK Laboratories, had been selected to develop vaccines.

He further revealed that the National Vaccine Institute was in discussions with a European partner about collaborating on cancer vaccine research using mRNA technology.

President Mahama urged Ghanaians to support clinical trials, describing them as an essential part of developing vaccines locally.

“And so if we are developing our own internal capacity to develop vaccines, we must accept to take part in the clinical trials. Nobody will do the clinical trials for us to develop vaccines in our country. And so that is my message to you,” he said.

The Vaccine Research Facility was commissioned alongside the Human Identification Laboratory, popularly known as the DNA Lab, at the Noguchi Memorial Institute for Medical Research.

K
Kofi Mensah Staff Journalist

Senior Political & Parliamentary Correspondent for Ghanamma. Covers governance, constitutional law, and national elections in Accra.

Ghanamma Editorial Standards: This report has been prepared and verified in accordance with Ghanamma.com's editorial code of ethics. Factual inquiries, right of reply, or corrections may be submitted directly to our newsroom at corrections@ghanamma.com. 📰 Syndicated wire assistance & reporting credit: Starr FM.
Share: WhatsApp WhatsApp
💬

Comments (0)

Join the Conversation

No comments yet. Be the first to share your opinion!

You may like